Avita Medical (RCEL) announced that its board of directors has appointed Cary Vance as president and CEO, effective immediately. The board of directors has also appointed Jan Stern Reed as its chair, effective immediately. Vance, who has served as interim CEO since October 2025, will continue to serve on the board as an executive member. Vance has served on the Avita Medical board of directors since 2023 and was previously appointed chairman in 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCEL:
- Avita Medical receives regulatory clearance for Recell Go
- Avita Medical (RCEL): Buy Rating on Cohealyx-I Data Validating a High-Growth Wound Care Platform
- Avita Medical announces interim results from Cohealyx-I multi-center study
- Avita Medical secures 10-year BARDA agreement worth $25.5M
- Avita Medical stock pullback creates buying opportunity, says Northland